Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Blood Culture Testing: Send Samples Selectively to Lower Costs, Medico-Legal Risk

By Jeremiah D. Schuur, MD, MHS and Michelle Lin, MD, MPH | on September 12, 2014 | 2 Comments
Cost-Effective Care
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
"Arm Yourself For the ""Cultural"" Debate "

You Might Also Like
  • Blood Culture of Limited Value in Most Kids Hospitalized with Community-Acquired Pneumonia
  • Praise for Evidence-Based Advice on Prescribing Antibiotics, Testing Blood Cultures
  • Should Emergency Department Patients with Pending Blood Cultures be Admitted?
Explore This Issue
ACEP Now: Vol 33 – No 09 – September 2014

Your last patient on a shift is a 55-year-old well-appearing woman with fever and cough in whom you suspect community-acquired pneumonia. As she steps in to draw labs, your nurse asks you, “Doc, two sets of cultures, right?”

In 2010, 4.1 percent of emergency department patients received blood culture testing.1 Each set of blood cultures costs $28 to process, with additional costs for microscopy and pathogen identification if there is growth, amounting to more than $151 million in annual medical costs based on Medicare reimbursement rates (a low estimate as many insurers and the uninsured are charged more than Medicare reimbursement rates).2

Blood culture bottles. Bacteriology laboratory.

Blood culture bottles. Bacteriology laboratory.

Blood cultures test for bacteremia, a condition associated with high mortality. However, they are frequently ordered on patients with clinical diagnoses for which they add little value. The true-positive rate of blood cultures based on prospective studies is as low as 4.1 percent to 7 percent.3 Up to 40 percent of positive blood cultures are false-positive from contaminants, resulting in prolonged hospital stays, avoidable testing (such as repeat cultures and echocardiograms), and antibiotic use. False-positive blood cultures are associated with three to five day increases in hospital length of stay and $4,400 to $8,800 in additional costs compared with true negatives.4,5 without culture data.

The true-positive rate of blood cultures based on prospective studies is as low as 4.1 percent to 7 percent. Up to 40 percent of positive blood cultures are
false positive.

Common Clinical Scenarios in Which Blood Cultures Are Unnecessary

Patients with community-acquired pneumonia. These patients should not routinely receive blood culture testing. Per the 2009 ACEP Clinical Policy, “Critical Issues in the Management of Adult Patients with Community-Acquired Pneumonia,” patients who do not require admission to the ICU and are not immunocompromised (eg, leukopenia, chronic alcohol abuse, liver disease, or steroids) are at low risk for bacteremia.6 Positive blood cultures rarely change management in pneumonia; retrospective studies document that only 0.4 percent to 3.4 percent of patients had antibiotic coverage changed.7 While the Centers for Medicare & Medicare Services (CMS) and The Joint Commission previously required blood cultures be drawn in the ED prior to administration of antibiotics as a pneumonia quality measure, this has been retired as of Jan. 1, 2014. The same is true for children. The Pediatric Infectious Diseases Society and the Infectious Diseases Society of America discourage routine blood cultures in their clinical practice guidelines.8

Pages: 1 2 3 4 | Single Page

Topics: Cost of Health CareEmergency MedicineLab TestLegalPractice ManagementQuality

Related

  • Florida Emergency Department Adds Medication-Dispensing Kiosk

    November 7, 2025 - 1 Comment
  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment
  • How Does Emergency Medicine Navigate Consolidation Trends in Health Care?

    October 29, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

About the Authors

Jeremiah D. Schuur, MD, MHS

Jeremiah D. Schuur, MD, MHS, is vice chair of quality and safety and chief of the Division of Health Policy Research and Translation in the Department of Emergency Medicine, Brigham & Women’s Hospital in Boston. He also serves as assistant professor at Harvard Medical School.

View this author's posts »

Michelle Lin, MD, MPH

Michelle Lin, MD, MPH, is an attending emergency physician and a fellow in the Division of Health Policy Research and Translation in the Department of Emergency Medicine, Brigham and Women’s Hospital in Boston. She also serves as an instructor at Harvard Medical School.

View this author's posts »

2 Responses to “Blood Culture Testing: Send Samples Selectively to Lower Costs, Medico-Legal Risk”

  1. October 4, 2014

    Culooch Reply

    Great article!

    In future versions would be useful to discuss the cost of false positive cultures (usually $4000-7000 per false positive in a hospitalized patient)

    Also it is not so important whether or not a culture is positive but rather how often does it change management. While 4% of ED drawn blood cultures may be positive (and half of those being false positives) a positive culture almost never prompts a change in abx. When it does, it is almost always in a immunosuppressed patient orthose with severe sepsis/septic shock

  2. June 10, 2015

    Delores Lyon Reply

    Wow, I had no idea that blood cultures could be so inaccurate. With a false positive testing rate of 40%, that is a lot of unnecessary follow up. In my opinion, if I was sick for some reason, I would probably want my doctor to forego something like this. The last thing I want is unnecessary medical bills.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603